Home › Pharmacology › Metoclopramide

Metoclopramide

Metoclopramidum

For medical students2 min readUpdated 2026-10-10

Metoclopramide is a mixed-action prokinetic agent and potent antiemetic drug. The medication accelerates gastric emptying and blocks specific receptors in the chemoreceptor trigger zone of the vomiting center, effectively relieving nausea, vomiting, and hiccups.

Pharmacological classProkinetic, antiemetic

Onset of actionRapid effect — within 5–15 minutes after administration

BarriersFreely crosses the blood-brain barrier (BBB)

InteractionsSignificantly alters the absorption rate of other drugs in the intestine

Mechanism of Action

The pharmacodynamics of metoclopramide comprise two complementary components: central and peripheral.

Central Action: The drug readily crosses the blood-brain barrier. In brain structures, it blocks dopamine ($D_2$) and serotonin ($5-HT_3$) receptors located in the chemoreceptor trigger zone of the vomiting center. This mechanism accounts for its pronounced antiemetic effect.
Peripheral (Prokinetic) Action: Within the gastrointestinal tract, metoclopramide acts as a motility stimulator. It increases the tone of the lower esophageal sphincter, enhances propulsive gastric peristalsis, and simultaneously relaxes the pyloric sphincter. As a result, gastric emptying into the duodenum is significantly accelerated.

Indications and Contraindications

The drug is administered orally or parenterally (in severe cases). Its primary indication is the management of dyspeptic disorders and delayed gastric emptying.

Main Indications:

Nausea and vomiting of various etiologies (including postoperative, post-anesthesia, radiation-induced, or hyperemesis gravidarum).
Drug-induced emesis (e.g., from cytostatics or cardiac glycosides).
Symptomatic treatment of acute migraine attacks (for relieving associated vomiting).

Contraindications:

Mechanical GI obstructions, perforation, or gastrointestinal bleeding.
Muscle dyskinesia (especially induced by neuroleptics).
Breastfeeding period.

Side Effects

The adverse reactions of metoclopramide directly stem from its receptor profile and its ability to penetrate the central nervous system.

Central Nervous System Effects: Unlike domperidone, which is actively effluxed from the brain by P-glycoprotein transporter proteins, metoclopramide accumulates in the CNS. Blockade of $D_2$ receptors in the brain can lead to extrapyramidal symptoms (EPS).
Endocrine Abnormalities: Blockade of dopaminergic pathways increases prolactin levels (hyperprolactinemia), which can manifest as amenorrhea and gynecomastia.
Gastrointestinal Effects: Enhanced motility naturally leads to increased stool frequency (diarrhea) and flatulence.

Effect on Pharmacokinetics of Other Drugs

The small intestine is the primary site of absorption for most pharmacological agents. The rate at which chyme leaves the stomach is critical for the bioavailability of other drugs.

Administration of prokinetics such as metoclopramide radically accelerates gastric emptying.

Enhanced Absorption: Rapid delivery to the intestine leads to intensive absorption of weak bases (e.g., propranolol, codeine).
Reduced Efficacy: For drugs with slow absorption (such as iron preparations and digoxin), accelerated transit is detrimental. The drug simply does not have enough time to be absorbed, leading to a sharp drop in its blood concentration and reduced therapeutic efficacy.

Mnemonic

To remember the receptor profile: Metoclopramide says 'Do Fast!' — blocking Dopamine and Serotonin ($5-HT_3$) receptors while accelerating peristalsis.

Frequently asked questions

What are the contraindications for the use of metoclopramide?

Contraindications for metoclopramide include:

Gastrointestinal bleeding;
GI perforation;
Muscle dyskinesia associated with neuroleptic use;
Breastfeeding.

What specific extrapyramidal symptoms can metoclopramide cause?

Metoclopramide references specifically note the development or exacerbation of parkinsonism due to blood-brain barrier penetration and central dopamine receptor blockade. Overdose rapidly triggers extrapyramidal symptoms.

Which peripheral receptors does metoclopramide interact with to enhance GI motility?

To enhance gastrointestinal motility, metoclopramide exerts a complex effect on multiple peripheral receptor types. It interacts with:

$D_2$ receptors (dopamine) — blockade (antidopaminergic effect);
$5-HT_4$ receptors (serotonin) — direct stimulation;
$5-HT_3$ receptors (serotonin) — blockade.

This interaction is localized primarily in the upper GI tract, leading to increased tone of the lower esophageal sphincter, relaxation of the pyloric sphincter, and stimulation of peristalsis.

Why does metoclopramide cause extrapyramidal symptoms while domperidone does not?

Metoclopramide easily crosses the BBB and blocks dopamine receptors in the brain. Domperidone is a substrate for P-glycoprotein, a protective efflux pump that actively transports the drug back into the bloodstream, preventing it from acting within the CNS.

Why is metoclopramide prescribed as part of combination therapy for migraines?

During a migraine attack, severe nausea and vomiting frequently occur. Metoclopramide is used symptomatically specifically to manage these dyspeptic symptoms while other medications (such as triptans) target the pain itself.

How will concurrent administration of metoclopramide affect digoxin therapy?

Metoclopramide enhances peristalsis and accelerates chyme transit through the intestine. Digoxin is absorbed slowly; therefore, rapid transit prevents adequate absorption, leading to a drop in its concentration and treatment failure.

Go deeper

Role of P-glycoprotein in blood-brain barrier function
Comparative profile of dopamine receptor antagonists
Influence of GI motility on drug pharmacokinetics
Strategies for symptomatic and prophylactic migraine therapy
Central and peripheral effects of antiemetics